Cyclo(Arg-Pro)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Cyclo(Arg-Pro)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Others
Catalog number
BAT-009977
Molecular Formula
C11H19N5O2
Molecular Weight
253.3
IUPAC Name
2-[3-[(3R,8aS)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-3-yl]propyl]guanidine
Synonyms
cyclo(Pro-Arg); 1-{3-[(3r,8as)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl}guanidine
Appearance
Lyophilized Powder
Purity
95%
Sequence
Cyclo(D-Arg-L-Pro-)
InChI
InChI=1S/C11H19N5O2/c12-11(13)14-5-1-3-7-10(18)16-6-2-4-8(16)9(17)15-7/h7-8H,1-6H2,(H,15,17)(H4,12,13,14)/t7-,8+/m1/s1
InChI Key
ZRJHYOXNWCMGMW-SFYZADRCSA-N
Canonical SMILES
C1CC2C(=O)NC(C(=O)N2C1)CCCN=C(N)N
1. Structure-based exploration of cyclic dipeptide chitinase inhibitors
Douglas R Houston, Bjørnar Synstad, Vincent G H Eijsink, Michael J R Stark, Ian M Eggleston, Daan M F van Aalten J Med Chem. 2004 Nov 4;47(23):5713-20. doi: 10.1021/jm049940a.
Family 18 chitinases play an essential role in a range of pathogens and pests. Several inhibitors are known, including the potent inhibitors argadin and allosamidin, and the structures of these in complex with chitinases have been elucidated. Recent structural analysis has revealed that CI-4 [cyclo-(L-Arg-D-Pro)] inhibits family 18 chitinases by mimicking the structure of the proposed reaction intermediate. Here we report the high-resolution structures of four new CI-4 derivatives, cyclo-(L-Arg-L-Pro), cyclo-(Gly-L-Pro), cyclo-(L-His-L-Pro), and cyclo-(L-Tyr-L-Pro), in complex with a family 18 chitinase. In addition, details of enzyme inhibition and in vivo activity against Saccharomyces cerevisiae are presented. The structures reveal that the common cyclo-(Gly-Pro) substructure is sufficient for binding, allowing modification of the side chain of the nonproline residue. This suggests that design of cyclic dipeptides with a view to increasing inhibition of family 18 chitinases should be possible through relatively accessible chemistry. The derivatives presented here in complex with chitinase B from Serratia marcescens provide further insight into the mechanism of inhibition of chitinases by cyclic dipeptides as well as providing a new scaffold for chitinase inhibitor design.
2. The cyclic dipeptide CI-4 [cyclo-(l-Arg-d-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate
Douglas R Houston, Ian Eggleston, Bjørnar Synstad, Vincent G H Eijsink, Daan M F van Aalten Biochem J. 2002 Nov 15;368(Pt 1):23-7. doi: 10.1042/BJ20021034.
Family 18 chitinases are attractive targets for the development of new inhibitors with chemotherapeutic potential against fungi, insects and protozoan/nematodal parasites. Although several inhibitors have been identified, these are based on complex chemistry, which hampers iterative structure-based optimization. Here we report the details of chitinase inhibition by the natural product peptide CI-4 [ cyclo -(L-Arg-D-Pro)], which possesses activity against the human pathogenic fungus Candida albicans, and describe a 1.7 A (0.17 nm) crystal structure of CI-4 in complex with the enzyme. The structure reveals that the cyclic dipeptide inhibits chitinases by structurally mimicking a reaction intermediate, and could, on the basis of its accessible chemistry, be a candidate for further optimization.
Online Inquiry
Verification code
Inquiry Basket